Depletion of deoxyribonucleoside triphosphate pools in tumor cells by nitric oxide.
D000818:Animals; D002460:Cell Line; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D006152:Cyclic GMP / Q000378:metabolism; D003841:Deoxycytidine / Q000378:metabolism; D003854:Deoxyribonucleotides / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008264:Macrophages / Q000378:metabolism; D051379:Mice; D009569:Nitric Oxide / Q000378:metabolism / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D009589:Nitrogen Oxides; D011355:Prodrugs / Q000378:metabolism / Q000494:pharmacology; D011743:Pyrimidines / Q000378:metabolism; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors; D013096:Spermine / Q000031:analogs & derivatives* / Q000494:pharmacology
D003854:Deoxyribonucleotides; D009589:Nitrogen Oxides; D011355:Prodrugs; D011743:Pyrimidines; D003841:Deoxycytidine; C091861:spermine nitric oxide complex; D013096:Spermine; D009569:Nitric Oxide; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse; D012264:Ribonucleotide Reductases; D006152:Cyclic GMP; C030986:pyrimidine